Logo
DeutschClear Cookie - decide language by browser settings
Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 11.

Article

Hallek, M.; Bergmann, M.; Emmerich, B. (2004): Chronic lymphocytic leukaemia: Up-dated recommendations on diagnosis and treatment. In: Onkologie, No. 1: pp. 97-104 [PDF, 88kB]

Straka, C.; Hebart, H.; Adler-Reichel, S.; Werding, N.; Emmerich, B.; Einsele, H. (2003): Blood stem cell collections after mobilization with combination chemotherapy containing ifosfamide followed by G-CSF in multiple myeloma. In: Oncology, No. 2: pp. 94-98 [PDF, 71kB]

Einsele, H.; Straka, C.; Emmerich, B.; Bamberg, M.; Budach, W. (2000): High-dose chemotherapy with hematopoietic stem cell transplantation for patients with advanced multiple myeloma. In: Onkologie, No. 3: pp. 272-274 [PDF, 48kB]

Adler, S.; Lang, S.; Langenmayer, Irmgard; Eibl-Eibesfeldt, B.; Rump, W.; Emmerich, B.; Hallek, M. (1994): Chronotherapy with 5-Fluorouracil and Folinic Acid in Advanced Colorectal Carcinoma. Results of a chronopharmacologic phase I trial. In: Cancer, Vol. 73, No. 12: pp. 2905-2912 [PDF, 773kB]

Pachmann, K.; Langenmayer, Irmgard; Straka, C.; Emmerich, B. (1994): Prevalence of CD20 positive B-cells in peripheral blood of patients with lymphocytic lymphoma and correlation with the course of disease. In: Onkologie, Supplements, Vol. 17, No. 430 [PDF, 187kB]

Straka, C.; Langenmayer, Irmgard; Drexler, E.; Pfefferkorn, L.; Pachmann, K.; Emmerich, B. (1994): A concept for the treatment of relapsed intermediate and high-grade NHL: Stem dell collection after IEV chemotherapy plus G.CSF, immunomagnetic purging of P.B.S.C. using Moabs against B-cell antigens in patients with CB/CC NHL and stem cell transplantation after high-dose BU/CY. In: Onkologie, Supplements, Vol. 17, No. 588 [PDF, 301kB]

Adler, S.; Lang, S.; Langenmayer, Irmgard; Eibl-Eibesfeldt, B.; Rump, W.; Emmerich, B.; Hallek, M. (1993): Chronotherapy with 5-Fluorouracil (5-FU) and folinic acid (FA) in advanced colorectal carcinoma: Results of a chronopharmacologic phase I/II trial. In: Annals of Hematology, Supplements, Vol. 67, No. 1a [PDF, 142kB]

Hallek, M.; Levi, F.; Langenmayer, Irmgard; Kammermeier, I.; Emmerich, B. (1993): Chronopharmacology of mitoxantrone (MX): Evodence for a circadian rhythm of its myelotoxicity from an animal model and a clinical pilot trial. In: Annals of Hematology, Supplements, Vol. 67, No. 45a [PDF, 146kB]

Knauf, W. U.; Langenmayer, Irmgard; Nerl, C.; Dietzfelbinger, H.; Mausbach, P.; Ziegler-Heitbrock, H. W.; Emmerich, B.; Thiel, E. (1992): Interferon-alpha 2b early phase chronic Lymphocytic Leukemia with high risk for progression-first results of a randomized multicenter AIO-Study. In: Onkologie, Vol. 15: pp. 55-57 [PDF, 733kB]

Emmerich, B.; Dengler, R.; Hohnloser, J.; Langenmayer, Irmgard (1992): Befundgraduierung und Stadieneinteilung in der Hämatologie und Onkologie am Beispiel der Leukämien, der Hodentumoren und des Mammakarzinoms. In: Der Internist, Vol. 33, No. 11: pp. 710-718 [PDF, 1MB]

Conference or Workshop Item

Knauf, W. U.; Langenmayer, Irmgard; Nerl, C.; Adolf, D.; Dietzfelbinger, H.; Maubach, P. A.; Ziegle-Heitbrock, H. W. L.; Emmerich, B.; Thiel, E. (1994): Interferon Alfa in the treatment of B-cell chronic lymphocytic leukemia. 2nd Frankfurt International Cytokine Symposium, 25. - 27. Juni 1992, Frankfurt am Main. [PDF, 1MB]

This list was generated on Sun May 29 15:35:11 2016 CEST.